Sign in

Jundishapur Journal of Natural Pharmaceutical Products

The Official Journal of Ahvaz Jundishapur University of Medical Sciences

e-ISSN 2228-7876
p-ISSN 1735-7780
Authors GuideSubmit manuscript
Cover image of the article: WITHDRAWN: A 4-week Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Use of Grape Seed Extract for Reducing Plasma Glucose, Lipid Profile, and Blood Pressure in Patients with Type 2 Diabetes Mellitus

Image Credit:Jundishapur J Nat Pharm Prod

Outline

https://doi.org/10.5812/jjnpp-142252

WITHDRAWN: A 4-week Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Use of Grape Seed Extract for Reducing Plasma Glucose, Lipid Profile, and Blood Pressure in Patients with Type 2 Diabetes Mellitus

Authors

Narjes ZaeemzadehNarjes Zaeemzadeh ORCID1, Marzieh Alavifar2, Amal Saki Malehi3, Mehrnoosh Zakerkish4,*
1Department of Phamacology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
*Corresponding Author: Diabetes Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Email: [email protected]
Jundishapur Journal of Natural Pharmaceutical Products:Vol. 19, issue 1; e142252
Published online:Jan 13, 2024
Article type:Research Article
Received:Oct 30, 2023
Accepted:Nov 24, 2023
How to Cite:Zaeemzadeh N, Alavifar M, Saki Malehi A, Zakerkish M. WITHDRAWN: A 4-week Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Use of Grape Seed Extract for Reducing Plasma Glucose, Lipid Profile, and Blood Pressure in Patients with Type 2 Diabetes Mellitus. Jundishapur J Nat Pharm Prod. 2024;19(1):e142252. doi: https://doi.org/10.5812/jjnpp-142252

Dear Readers,

We wish to inform you of the withdrawal of this article recently published in our journal (1). This decision comes after careful consideration and in accordance with the request of the authors.
The authors have provided the following statement regarding their decision (Ticket #512394): "Considering that the authors of the article have realized that the reported results require further review to ensure their accuracy, we request the withdrawal of the article."
The integrity and accuracy of the research we publish are of utmost importance to us. In line with this commitment, we respect the authors' decision to withdraw their article for a thorough review and verification of its results. We appreciate the authors' proactive approach to maintaining the quality and reliability of their work and the scientific record.
We understand that the withdrawal of an article may cause inconvenience to our readers, and we apologize for any confusion this may have caused. We thank you for your understanding and continued support of our journal's dedication to the highest standards of scientific publishing.
Sincerely,
Masood Fereidoonnezhad
EIC

References

  • 1.
    Zaeemzadeh N, Alavifar M, Saki Malehi A, Zakerkish M. A 4-week Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Use of Grape Seed Extract for Reducing Plasma Glucose, Lipid Profile, and Blood Pressure in Patients with Type 2 Diabetes Mellitus. Jundishapur J Nat Pharm Prod. 2023;19(1). https://doi.org/10.5812/jjnpp-142252.

Copyright

Copyright © 2024, Zaeemzadeh et al. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

13
May
2024
A 4-week Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Use of Grape Seed Extract for Reducing Plasma Glucose, Lipid Profile, and Blood Pressure in Patients with Type 2 Diabetes Mellitus

A 4-week Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Use of Grape Seed Extract for Reducing Plasma Glucose, Lipid Profile, and Blood Pressure in Patients with Type 2 Diabetes Mellitus

Narjes Zaeemzadeh,
Mehrnoosh Zakerkish,
Marzieh Alavifar,
Amal Saki Malehi
PDF

Zaeemzadeh N, Zakerkish M, Alavifar M, Saki Malehi A. A 4-week Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Use of Grape Seed Extract for Reducing Plasma Glucose, Lipid Profile, and Blood Pressure in Patients with Type 2 Diabetes Mellitus. Jundishapur J Nat Pharm Prod. 2024;19(3):e146854. doi: https://doi.org/10.5812/jjnpp-146854

8
Jul
2026

Retracted: Magnesium Gargle Versus Ketamine Gargle in Postoperative Sore Throat Pain; A Randomized Placebo-Controlled Clinical Trial [J Cell Mol Anesth. 2020;5(3): e149598]

Houman Teymourian,
Nima Saeedi,
Gholamreza Mohseni,
Shayesteh Khorasanizadeh,
Nastaran Hajizade
PDF

Teymourian H, Saeedi N, Mohseni G, Khorasanizadeh S, Hajizade N. Retracted: Magnesium Gargle Versus Ketamine Gargle in Postoperative Sore Throat Pain; A Randomized Placebo-Controlled Clinical Trial [J Cell Mol Anesth. 2020;5(3): e149598]. J Cell Mol Anesth. 2020;5(3):e149598. doi: https://doi.org/10.22037/jcma.v5i3.29471

22
Jun
2020
WITHDRAWN ARTICLE: Effect of Sesame Lignan Supplementation on Carotid Intima-Media Thickness, Serum Lipid Profile, Serum VEGF, VCAM-1, ICAM-1 and vWF Levels in Cardiovascular Disease Patients

WITHDRAWN ARTICLE: Effect of Sesame Lignan Supplementation on Carotid Intima-Media Thickness, Serum Lipid Profile, Serum VEGF, VCAM-1, ICAM-1 and vWF Levels in Cardiovascular Disease Patients

Marzieh Mokhber,
Seyyed Ali Keshavarz,
Farzad Shidfar,
Abbas Hadji Akhundi,
Hamidreza Pouraliakbar,
Zahra Nazem Bokaee
,et al.
PDF

Mokhber M, Keshavarz SA, Shidfar F, Hadji Akhundi A, Pouraliakbar H, et al. WITHDRAWN ARTICLE: Effect of Sesame Lignan Supplementation on Carotid Intima-Media Thickness, Serum Lipid Profile, Serum VEGF, VCAM-1, ICAM-1 and vWF Levels in Cardiovascular Disease Patients. Int J Endocrinol Metab. 2021;19(1):e82984. doi: https://doi.org/10.5812/ijem.82984

16
Apr
2025
Erratum to “Is There Any Correlation Between QT Dispersion and Echocardiographic Indices in Term Neonates with and Without Maternal Gestational Diabetes Mellitus?” [J Compr Ped. 2023; 14(3): e132915]

Erratum to “Is There Any Correlation Between QT Dispersion and Echocardiographic Indices in Term Neonates with and Without Maternal Gestational Diabetes Mellitus?” [J Compr Ped. 2023; 14(3): e132915]

Marjaneh Zarkesh,
Seyyedeh Azade Hoseini Nouri,
Manijeh Tabrizi,
Esfandiar Nazari,
Atbin Latifi,
Sadroddin Mahdipour
,et al.
PDF

Zarkesh M, Hoseini Nouri SA, Tabrizi M, Nazari E, Latifi A, et al. Erratum to “Is There Any Correlation Between QT Dispersion and Echocardiographic Indices in Term Neonates with and Without Maternal Gestational Diabetes Mellitus?” [J Compr Ped. 2023; 14(3): e132915]. J Compr Ped. 2025;16(2):e159427. doi: https://doi.org/10.5812/jcp-159427

25
Feb
2023
A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients

A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients

Shima Afshar,
Shayesteh Khalili,
Gholamreza Amin,
Mohammad Abbasinazari
PDF

Afshar S, Khalili S, Amin G, Abbasinazari M. A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients. Iran J Pharm Res. 2022;21(1):e132647. doi: https://doi.org/10.5812/ijpr-132647

More by these authors

Narjes ZaeemzadehPubMedScholar
Marzieh AlavifarPubMedScholar
Amal Saki MalehiPubMedScholar
Mehrnoosh ZakerkishPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF69.33 KB
Import into EndNoteImport into BibTex
Share
Cited by
Metrics
Comments
Number of Comments:0
Indexed in
logoScopus